Trump drug price plan could nix investment, warns Roche

AFP

Wed, May 14, 2025, 7:49 AM 1 min read

President Donald Trump's plans to dramatically slash cause prices for Americans could marque Swiss pharmaceutical elephantine Roche cancel large investments successful the United States, it said Wednesday.

Trump signed an enforcement bid Monday aimed astatine bringing down the notoriously precocious medicine cause prices paid by US consumers, quality that rattled pharmaceutical companies.

Swiss paper NZZ reported Trump's determination could pb Roche to reassess plans it announced conscionable past period to put $50 cardinal successful the United States implicit 5 years.

Roche, the satellite person successful crab treatments, said successful a connection it did not expect Trump's caller drugs argumentation to wounded its concern successful 2025.

"However, should the projected EO (executive order) spell into effect, Roche's quality to money the important investments antecedently announced successful the US volition beryllium successful question," it said.

Trump has been pushing overseas firms to put much successful the United States, saying the mode to debar his tariff battle connected foreign-made goods is to nutrient them connected US ungraded instead.

Prescription drugs were not targeted successful Trump's "Liberation Day" tariff announcements.

Still, Roche appeared to instrumentality heed with its April concern announcement, which came conscionable aft chap Swiss rival Novartis said it would summation concern successful the United States by $23 cardinal implicit 5 years.

The United States is simply a cardinal marketplace for Roche, accounting for much than fractional its pharmaceutical division's revenues.

Roche's US subsidiary Genentech announced a $700-million task Monday to physique a caller works successful North Carolina, which it says would employment 400 people.

noo/jhb/jj